logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. Nucleoside Metabolic Inhibitor

    Nucleoside Metabolic Inhibitor class drugs

    FiltersReset Filters
    16 results

    • decitabine

      (Decitabine)
      Meitheal Pharmaceuticals Inc.
      Usage: Decitabine for Injection is indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including various subtypes and risk groups, both previously treated and untreated, de novo and secondary MDS.

    • fluorouracil

      (Fluorouracil)
      Alembic Pharmaceuticals Inc.
      Usage: Fluorouracil is indicated for the treatment of patients with adenocarcinoma of the colon and rectum, breast, gastric, and pancreatic adenocarcinoma.

    • fluorouracil

      (Fluorouracil)
      Meitheal Pharmaceuticals Inc.
      Usage: Fluorouracil Injection is indicated for treating adenocarcinoma of the colon and rectum, breast, stomach, and pancreas.

    • fluorouracil

      (Fluorouracil)
      BluePoint Laboratories
      Usage: Fluorouracil is indicated for treating patients with adenocarcinoma of the colon and rectum, breast, stomach, and pancreas.

    • fluorouracil

      (Fluorouracil)
      BluePoint Laboratories
      Usage: Fluorouracil is indicated for the treatment of patients with adenocarcinomas, specifically of the colon and rectum, breast, gastric, and pancreas.

    • fluorouracil

      (Fluorouracil)
      Meitheal Pharmaceuticals Inc.
      Usage: Fluorouracil Injection is indicated for the treatment of adenocarcinoma of the colon and rectum, breast, stomach, and pancreas.

    • fluorouracil

      (Fluorouracil)
      Alembic Pharmaceuticals Inc.
      Usage: This drug is indicated for the treatment of various adenocarcinomas, specifically adenocarcinoma of the colon and rectum, breast, gastric, and pancreatic regions.

    • fluorouracil

      (FLUOROURACIL)
      Eugia US LLC
      Usage: Fluorouracil injection is indicated for treating patients with adenocarcinoma of the colon, rectum, breast, stomach, and pancreas.

    • fluorouracil

      (fluorouracil)
      Sagent Pharmaceuticals
      Usage: Fluorouracil Injection is indicated for treating adenocarcinoma of the colon and rectum, breast, gastric, and pancreatic cancer.

    • fluorouracil

      (FLUOROURACIL)
      Eugia US LLC
      Usage: Fluorouracil injection is indicated for treating adenocarcinomas of the colon, rectum, breast, stomach, and pancreas.